Average cost of care in year after ovarian cancer surgery around $100K

November 9, 2017

(HealthDay)—For women with ovarian cancer who underwent both surgery and adjuvant chemotherapy, the average medical expenditures are about $100,000 in the first year after surgery, according to a study published online Nov. 7 in Obstetrics & Gynecology.

Alexandra S. Bercow, M.D., from Columbia University College of Physicians and Surgeons in New York City, and colleagues conducted a of women with diagnosed from 2009 to 2012 who underwent both surgery and . Medical expenditures were estimated for a 12-month period beginning on the date of surgery; all payments, including out-of-pocket costs, were examined. Data were included for 5,031 women after exclusion of patients with incomplete insurance enrollment or coverage, those who did not undergo chemotherapy, and those with capitated plans.

The researchers found that during the first year after the index procedure, the median total medical expenditures per patient were $93,632. Inpatient services accounted for 37.8 percent in expenditures ($30,708); outpatient services for 58.3 percent ($52,700); and outpatient drug costs for 3.8 percent ($1,814). The median out-of-pocket expense was $2,998, which included $1,509, $589, and $351 for outpatient services, inpatient services, and outpatient drug costs, respectively.

"The average cost of care for women with ovarian cancer in the first year after surgery is approximately $100,000. Patients bear approximately 3 percent of these costs in the form of out-of-pocket expenses," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Explore further: New VTE often occurs during chemo in ovarian cancer

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

New VTE often occurs during chemo in ovarian cancer

May 11, 2017
(HealthDay)—For patients with ovarian cancer, new diagnosis of venous thromboembolism frequently occurs during neoadjuvant or adjuvant chemotherapy, according to a study published in the June issue of Obstetrics and Gynecology.

Surgery, chemo best for elderly with advanced ovarian cancer

December 29, 2015
(HealthDay)—Primary debulking surgery and chemotherapy in an optimal timeframe is associated with the longest survival time for elderly women with advanced ovarian cancer, according to a study published in the January issue ...

Five-year risk of repeat SUI, POP surgery less than 10 percent

May 23, 2017
(HealthDay)—For women undergoing surgery for stress urinary incontinence (SUI) and pelvic organ prolapse (POP), the risk of repeat procedures is less than 10 percent, with increased risks for older women and initial POP ...

Kidney disease patients have higher out-of-pocket costs than stroke and cancer patients

January 17, 2017
Patients who have chronic kidney disease but are not on dialysis have higher out-of-pocket healthcare expenses than even stroke and cancer patients, according to a study by researchers at Loyola University Chicago and Loyola ...

More women choose breast reconstruction after mastectomy

October 13, 2017
(HealthDay)—Over five years, the proportion of U.S. breast cancer patients opting for breast reconstruction after mastectomy grew by about two-thirds, a new government report shows.

Survival similar with debulking by laparotomy, laparoscopy

April 10, 2017
(HealthDay)—For women with epithelial ovarian cancer, three-year survival rates are similar for women undergoing debulking by laparotomy or laparoscopy, according to a study published in the May issue of Obstetrics & Gynecology.

Recommended for you

A small, daily dose of Viagra may reduce colorectal cancer risk

March 19, 2018
A small, daily dose of Viagra significantly reduces colorectal cancer risk in an animal model that is genetically predetermined to have the third leading cause of cancer death, scientists report.

Machine-learning algorithm used to identify specific types of brain tumors

March 15, 2018
An international team of researchers has used methylation fingerprinting data as input to a machine-learning algorithm to identify different types of brain tumors. In their paper published in the journal Nature, the team ...

Higher doses of radiation don't improve survival in prostate cancer

March 15, 2018
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology ...

Joint supplement speeds melanoma cell growth

March 15, 2018
Chondroitin sulfate, a dietary supplement taken to strengthen joints, can speed the growth of a type of melanoma, according to experiments conducted in cell culture and mouse models.

Improved capture of cancer cells in blood could help track disease

March 15, 2018
Tumor cells circulating throughout the body in blood vessels have long been feared as harbingers of metastasizing cancer - even though most free-floating cancer cells will not go on to establish a new tumor.

Area surrounding a tumor impacts how breast cancer cells grow

March 14, 2018
Cancer is typically thought of as a tumor that needs to be removed or an area that needs to be treated with radiation or chemotherapy. As a physicist and cancer researcher, Joe Gray, Ph.D., thinks differently.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Nov 09, 2017
See my comment under today's heading.. Cancer drug parity laws lower costs for many, but not everyone.. an learn how to prevent 98% and cure most, based on over 1/2million reproducible bio-resonance tests.by Dr H R Clark PhD ND.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.